CA2458782A1 - Compositions et methodes permettant de traiter des sujets souffrant d'hyperglycemie - Google Patents

Compositions et methodes permettant de traiter des sujets souffrant d'hyperglycemie Download PDF

Info

Publication number
CA2458782A1
CA2458782A1 CA002458782A CA2458782A CA2458782A1 CA 2458782 A1 CA2458782 A1 CA 2458782A1 CA 002458782 A CA002458782 A CA 002458782A CA 2458782 A CA2458782 A CA 2458782A CA 2458782 A1 CA2458782 A1 CA 2458782A1
Authority
CA
Canada
Prior art keywords
extract
partially
banaba
purified
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002458782A
Other languages
English (en)
Inventor
Xiaozhuo Chen
Fang Liu
Yungsheng Li
Jing Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2458782A1 publication Critical patent/CA2458782A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention concerne un extrait de plantes partiellement purifié permettant de traiter des sujets atteints d'hyperglycémie. Cet extrait de plantes partiellement purifié comprend une pluralité de composés hydrosolubles ayant un poids moléculaire supérieur à 800 et inférieur à 1500 grammes/mole. L'un des composés de l'extrait de plantes partiellement purifié est le gallotannin hydrolysable, connu sous le nom de penta-O-galloyl-D-glucose. L'extrait de plantes partiellement purifié est sensiblement dépourvu de triterpénoïdes, notamment d'acide corosolique et de tanins ellagiques à poids moléculaire élevée, c'est-à-dire des tanins ellagiques ayant un poids moléculaire supérieur à 1500 grammes/mole. Dans un mode de réalisation idéal, ledit extrait de plantes partiellement purifié est dérivé de la plante tropicale Lagerstroemia Speciosa L, également connue sous le nom de banaba. L'invention concerne également une méthode d'utilisation dudit extrait de plantes partiellement purifié afin de traiter les sujets atteints d'hyperglycémie.
CA002458782A 2001-08-31 2002-09-03 Compositions et methodes permettant de traiter des sujets souffrant d'hyperglycemie Abandoned CA2458782A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31662401P 2001-08-31 2001-08-31
US60/316,624 2001-08-31
PCT/US2002/027996 WO2003018043A1 (fr) 2001-08-31 2002-09-03 Compositions et methodes permettant de traiter des sujets souffrant d'hyperglycemie

Publications (1)

Publication Number Publication Date
CA2458782A1 true CA2458782A1 (fr) 2003-03-06

Family

ID=23229876

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002458782A Abandoned CA2458782A1 (fr) 2001-08-31 2002-09-03 Compositions et methodes permettant de traiter des sujets souffrant d'hyperglycemie

Country Status (5)

Country Link
EP (1) EP1427429A4 (fr)
JP (1) JP2005502666A (fr)
CN (1) CN1578669A (fr)
CA (1) CA2458782A1 (fr)
WO (1) WO2003018043A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005063228A1 (ja) * 2003-12-26 2007-07-19 株式会社ユース・テクノコーポレーション 耐糖能改善剤
JP2008525497A (ja) * 2004-12-22 2008-07-17 ルネサンス ハーブス インコーポレイテッド オオバナサルスベリ植物に由来する医薬組成物、治療組成物、及び食品組成物
KR100693400B1 (ko) 2005-06-30 2007-03-09 주식회사 삼양제넥스 식물 세포 현탁 배양에 의한 코로솔릭산의 제조방법
CN100564392C (zh) * 2006-04-18 2009-12-02 上海诺德生物实业有限公司 一种三萜类化合物的提取、制备方法
JP5032801B2 (ja) * 2006-06-30 2012-09-26 石原産業株式会社 高純度１，２，３，４，６−ペンタ−Ｏ−ガロイル−β−Ｄ−グルコピラノースの製造方法
JP2011184351A (ja) * 2010-03-08 2011-09-22 Nitta Gelatin Inc 抗肥満剤
KR102460344B1 (ko) * 2015-09-08 2022-10-31 주식회사 케이오씨바이오텍 돌콩과 바나바잎 복합물을 포함하는 항당뇨 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818458B2 (ja) * 1989-12-28 1998-10-30 株式会社伊藤園 バナバ飲用物の製造方法
JPH05310587A (ja) * 1992-03-11 1993-11-22 Itouen:Kk バナバ葉抽出物と使用方法並びに抗糖尿病剤
JP3507116B2 (ja) * 1994-02-18 2004-03-15 株式会社 伊藤園 コレステロール上昇抑制作用剤
JP3507115B2 (ja) * 1994-02-18 2004-03-15 株式会社 伊藤園 バナバ葉抽出物と抗糖尿病剤
JP2000169384A (ja) * 1998-12-09 2000-06-20 Yuusu Techno Corporation:Kk 血糖値上昇抑制乃至下降用組成物
ATE282422T1 (de) * 1999-05-25 2004-12-15 Use Techno Corp Flüssige zubereitung zum verdampfen gegen erhöhung des blutzuckerspiegels und verdampfer für dieselbe

Also Published As

Publication number Publication date
JP2005502666A (ja) 2005-01-27
WO2003018043A1 (fr) 2003-03-06
EP1427429A1 (fr) 2004-06-16
EP1427429A4 (fr) 2006-11-02
CN1578669A (zh) 2005-02-09

Similar Documents

Publication Publication Date Title
Shang et al. Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes
KR101934328B1 (ko) 아모디아퀸 및 항당뇨 약물을 유효성분으로 함유하는 당뇨병의 예방 또는 치료용 약학적 조성물
Huang et al. Arginase-2 protects myocardial ischemiareperfusion injury via NF-κB/TNF-α pathway.
EP3199171B1 (fr) Composition pharmaceutique destinée à traiter et à prévenir des troubles neurologiques dégénératifs contenant, comme principe actif, un extrait de mélange d'écorce de racine de pivoine arborescente, de racine d'angelica dahurica et de racine de bupleurum ou une fraction de celui-ci
US20220133763A1 (en) Composition containing nicotinamide mononucleotide and mogroside, and application thereof
CA2458782A1 (fr) Compositions et methodes permettant de traiter des sujets souffrant d'hyperglycemie
TW201206865A (en) Polyacetylenic compounds for protecting against pancreatic islet atrophy
US20060058243A1 (en) Methods and compositions for treating diabetes mellitis
Goh et al. Effects of bamboo stem extracts on adipogenic differentiation and lipid metabolism regulating genes
KR101193540B1 (ko) 황기，계지 및 황백의 혼합생약재 추출물을 포함하는 골다공증 및 골질환 예방 및 치료용 조성물
US20040258773A1 (en) Composition and methods for treating subjects with hyperglycemia
WO2004009094A1 (fr) Methodes et compositions permettant de traiter les diabetes sucres
US20180193401A1 (en) Anti-obesity composition comprising natural complex
JP2012072136A (ja) 細胞内代謝促進用組成物、その組成物を含有する糖代謝又は脂質代謝疾患の予防及び／又は治療用医薬製剤、機能性食品及び健康食品
KR101796034B1 (ko) 증포발효 인삼열매 추출물을 유효성분으로 함유하는 비만 치료용 조성물
Abubakar et al. In vitro antidiabetic potentials of crude saponins extract from Leptodenia hastata and Adansonia digitata leaves
KR100892120B1 (ko) 제 2 형 당뇨병 치료 또는 예방용 약학적 조성물
CN111249271A (zh) 用于治疗糖尿病的药剂及其制备方法和应用
US20240156889A1 (en) A method for reducing animal weight
KR102177776B1 (ko) 가디퀴모드를 유효성분으로 포함하는 근력 약화 관련 질환 치료용 조성물
KR102519208B1 (ko) 해삼 생식선 추출물을 포함하는 조성물, 해삼 난소 추출물로부터 유래된 화합물, 및 이의 용도
US11925671B2 (en) Process and compositions for enhancing energy expenditure
WO2020036257A1 (fr) Composition contenant du méthyl sulfonyl méthane destinée à prévenir ou à soulager l'obésité, la stéatose hépatique et le diabète
Zainah et al. The enhancement effect of Ficus deltoidea on glucose uptake activity into liver cells
Lawal et al. In vitro antidiabetic potentials of crude saponins extract from Leptodenia hastata and Adansonia digitata leaves

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead